Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.

NCT06514313 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine
DRUG: Temozolomide+Irinotecan+Vincristine

Sponsor

Yizhuo Zhang